KIMIABL

KIMIA BIOSCIENCES financials

Market cap
₹169 Cr

Quarterly results

Q1 FY27: revenue down 12.1%, net profit down 40.0% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue28 30 38 24 34 +21%30 +0%27 −29%21 −12%
EBITDA3 5 8 3 3 −25%7 +31%3 −67%2 −7%
Net profit2 5 2 1 1 −37%5 +19%0 −81%0 −40%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance −24.2% 1Y

₹25.0₹30.0₹35.0₹40.0Sept 25Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26

1Y: ₹35.92 on 10 Sept 2025 → ₹27.24. High ₹39.95 (13 Feb 2026), low ₹23.55 (30 Mar 2026).

Financials, as filed

Revenue grew 4.7% a year over 2 years, FY24 to FY26. Operating margin widened to 12.4%.

Year endingFY24FY25FY26
Revenue₹105 Cr₹119 Cr₹115 Cr
Operating profit₹-0 Cr₹20 Cr₹14 Cr
Operating margin-0.5%17.0%12.4%
Interest₹5 Cr₹5 Cr₹4 Cr
Depreciation₹3 Cr₹3 Cr₹4 Cr
Net profit₹-5 Cr₹10 Cr₹7 Cr
Net margin-5.1%8.1%6.5%
Cash from operations₹15 Cr₹21 Cr₹11 Cr
Free cash flow₹13 Cr₹17 Cr₹3 Cr
ROCE-4.0%42.0%25.0%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr
Reserves₹14 Cr₹10 Cr₹1 Cr₹-4 Cr₹7 Cr₹13 Cr
Borrowings₹45 Cr₹41 Cr₹53 Cr₹44 Cr₹36 Cr₹35 Cr
Other liabilities₹43 Cr₹54 Cr₹63 Cr₹56 Cr₹54 Cr₹51 Cr
Total liabilities₹107 Cr₹109 Cr₹121 Cr₹100 Cr₹101 Cr₹103 Cr
Fixed assets₹28 Cr₹35 Cr₹34 Cr₹32 Cr₹34 Cr₹37 Cr
Capital work in progress₹6 Cr₹0 Cr₹1 Cr₹1 Cr₹0 Cr₹0 Cr
Investments₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Other assets₹72 Cr₹74 Cr₹87 Cr₹68 Cr₹68 Cr₹66 Cr
Total assets₹107 Cr₹109 Cr₹121 Cr₹100 Cr₹101 Cr₹103 Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

The ownership split has held steady since Jun 2025. The shareholder count grew 5% to 12,775.

Promoters
74.9%
DIIs
0.4%
Public
24.7%

Since Jun 2025

  • Promoters 0.00 pp
  • DIIs 0.00 pp
  • Public 0.00 pp

How it drifted, 12 quarters

Sep '23Dec '24Jun '26

Ownership split by quarter, oldest first. Sep '23: Promoters 74.9%, DIIs 0.4%, Public 24.7%.Dec '23: Promoters 74.9%, DIIs 0.4%, Public 24.7%.Mar '24: Promoters 74.9%, DIIs 0.4%, Public 24.7%.Jun '24: Promoters 74.9%, DIIs 0.4%, Public 24.7%.Sep '24: Promoters 74.9%, DIIs 0.4%, Public 24.7%.Dec '24: Promoters 74.9%, DIIs 0.4%, Public 24.7%.Mar '25: Promoters 74.9%, DIIs 0.4%, Public 24.7%.Jun '25: Promoters 74.9%, DIIs 0.4%, Public 24.7%.Sep '25: Promoters 74.9%, DIIs 0.4%, Public 24.7%.Dec '25: Promoters 74.9%, DIIs 0.4%, Public 24.7%.Mar '26: Promoters 74.9%, DIIs 0.4%, Public 24.7%.Jun '26: Promoters 74.9%, DIIs 0.4%, Public 24.7%.

Who was buying across the market this quarter →

Who is on the register

Named in the Jun 2026 filing

Every holder of KIMIA BIOSCIENCES LIMITED above SEBI's 1% disclosure line, and what changed since Mar 2026.

HolderStakeChange
Sameer Goel 74.94%unchanged
Anish Kumar Aggarwal 4.33%unchanged
Manish Gupta 4.25%unchanged
Roma Mittal 4.11%unchanged
Rahul Agrawal 3.33%unchanged
Santosh Goel 0.00%unchanged
Vandana Goel 0.00%unchanged
Vipul Goel 0.00%unchanged

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

Learn to analyse KIMIA BIOSCIENCES LIMITED

Guides on how to read this kind of business and the numbers that matter.